Identifiable Intangible Assets and Goodwill - Finite-lived Intangible Assets Percentage of Total Intangibles (Details)	Jun. 28, 2015
Developed Technology Rights [Member] | Global Innovative Pharmaceutical [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	31.00%
Developed Technology Rights [Member] | Global Vaccines, Oncology and Consumer Healthcare [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	36.00%
Developed Technology Rights [Member] | Global Established Pharmaceutical [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	33.00%
Trade Names [Member] | Global Innovative Pharmaceutical [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	0.00%
Trade Names [Member] | Global Vaccines, Oncology and Consumer Healthcare [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	80.00%
Trade Names [Member] | Global Established Pharmaceutical [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	20.00%